New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
Details for Australian Patent Application No. 2003251731 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): 60/393,025 01.07.02 US
4 March 2004 Application Open to Public Inspection
Published as AU-B-2003251731
18 September 2008 Application Accepted
Published as AU-B-2003251731
6 November 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 16 Oct 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000
5 March 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 16 Oct 2008
5 March 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003251730-Bafilomycin-like metabolite from a novel Micromonospora species
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser